DTPA(DOTA)-Nimotuzumab Radiolabeling with Generator-produced Thorium for Radioimmunotherapy of EGFR-overexpressing Carcinomas
Article in Current Radiopharmaceuticals (January 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review
Article in Cancers (June 2021)
Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence
Article in Bioorganic & Medicinal Chemistry (January 2021)